Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials |
| BNF code | 1404000ATAAAUAU |
| Virtual Therapeutic Moiety | COVID-19 vaccine |
| Basis of preferred name | Other |
| Prescribing status | Never Valid To Prescribe As A VMP |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 0.500 |
| Unit dose form units | ml |
| Unit dose unit of measure | dose |
| Ontology Drug Form & Route | |
|---|---|
| Form & Route | suspensioninjection.intramuscular |
| Dose Form | |
| Formulation | Suspension for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (AstraZeneca AB) | |
| Virtual Medicinal Product Packs | |
| Generic COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials 10 dose | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.